These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 1232586)

  • 1. [Effect of a new derivative of 3-hydrazine pyridazine: ISF 2123 in hypertensive patients. Note 2].
    Ripa R; Abbondati G; Frisoni B; Farabegoli E; Tripodi G
    Minerva Cardioangiol; 1975 Dec; 23(12):901-5. PubMed ID: 1232586
    [No Abstract]   [Full Text] [Related]  

  • 2. [Activity of a new derivative of 3-hydrazinopyridazine: ISF 2123 in patients with hypertension. I].
    Ripa R; Abbondati G; Frisoni B; Tripodi G
    Minerva Cardioangiol; 1975 Nov; 23(11):735-47. PubMed ID: 1223677
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical pharmacology of a new hypotensive drug with peripheral vasodilating action (ISF 2123); effects of acute intravenous administration in hypertensive patients].
    Terzoli L; Bianchini C; Cornelli U; Sala C; Leonetti G; Zanchetti A
    Boll Soc Ital Cardiol; 1977; 22(7):1053-6. PubMed ID: 618241
    [No Abstract]   [Full Text] [Related]  

  • 4. [Double-blind clinical trial of a new pyridazine and its combination with reserpine in hypertensive patients].
    Di Veroli C; Petrucci D; Romeo B
    Clin Ter; 1977 Sep; 82(6):551-67. PubMed ID: 338239
    [No Abstract]   [Full Text] [Related]  

  • 5. [3-Hydrazinepyridazine derivatives. III. Synthesis and anti-hypertensive activity of new 3-(2-acylhydrazine)-pyridazine-6-alkylamino substitutes].
    Parravicini F; Scarpitta G; Dorigotti L; Pifferi G
    Farmaco Sci; 1979 Apr; 34(4):299-310. PubMed ID: 553832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Binazine--a new phthalazine derivative].
    Gamski M
    Z Gesamte Inn Med; 1973 Aug; 28(15):Suppl:234-5. PubMed ID: 4765564
    [No Abstract]   [Full Text] [Related]  

  • 7. Proceedings: Antihypertensive activity of a new 3-hydrazinopyridazine derivative: ISF 2123.
    Carpi C; Dorigotti L
    Br J Pharmacol; 1974 Nov; 52(3):459P. PubMed ID: 4458870
    [No Abstract]   [Full Text] [Related]  

  • 8. Onthe pharmacology of 3-hydrazino-6-(N,N-bis(2-hydroxyethyl)amino)-pyridazine-dihydrochloride (L 6150).
    Baldoli E; Sardi A; Dezulian V; Capellini M; Bianchi G
    Arzneimittelforschung; 1973 Nov; 23(11):1591-5. PubMed ID: 4801666
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effects of cadralazine (ISF 2469) on water-sodium balance and on essential arterial hypertension].
    Lavezzaro GC; Gastaldo D; Noussan P; Bensoni M; Parini J; Angelino PF
    Minerva Cardioangiol; 1981 Oct; 29(10):527-34. PubMed ID: 7322375
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical effectiveness of BQ 22-708, a pyridopyridazine derivative, in the treatment of fixed essential hypertension].
    Lehmann HU; Meyer-Estorf G; Hochrein H
    Med Welt; 1978 Jun; 29(24):1007-12. PubMed ID: 672563
    [No Abstract]   [Full Text] [Related]  

  • 11. Dose-response curve and time course of the antihypertensive effect of SKF 92 657, a beta-receptor-blocking and vasodilating compound.
    Leonetti G; Terzoli L; Sala C; Bianchini C; Zanchetti A
    Clin Sci (Lond); 1980 Dec; 59 Suppl 6():461s-463s. PubMed ID: 6108817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Open pilot study of the activity and tolerability of cadralazine in hypertensive patients resistant to other therapy].
    Angelino PF; Bensoni M; Gastaldo D; Minelli M; Parini M; Lavezzaro GC
    Minerva Cardioangiol; 1982 Mar; 30(3):69-74. PubMed ID: 7088296
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparative study of endralazine and captopril in essential hypertension: effect on renin levels, pulmonary function studies and lipid profile.
    Hauger-Klevene JH; Reader C; Mayer E; Sanchez MR
    Int J Clin Pharmacol Res; 1986; 6(4):275-81. PubMed ID: 3531038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical data on the antitumor activity of hydrazine sulfate.
    Gershanovich ML; Danova LA; Kondratyev VB; Malyugina LL; Stukov AN; Seitz JF; Filov VA
    Cancer Treat Rep; 1976 Jul; 60(7):933-5. PubMed ID: 1009524
    [No Abstract]   [Full Text] [Related]  

  • 15. A new antihypertensive compound: 3 hydrazino-6- [(2-hydroxypropyl)methylamino] pyridazine dihydrochloride (ISF 2123).
    Dorigotti L; Rolandi R; Carpi C
    Pharmacol Res Commun; 1976 Jun; 8(3):295-308. PubMed ID: 17122
    [No Abstract]   [Full Text] [Related]  

  • 16. Characteristics and clinical effects of ISF 2123, a new antihypertensive agent.
    Pellegrini R; Abbondati G
    Farmaco Prat; 1977 Jan; 32(1):19-24. PubMed ID: 838036
    [No Abstract]   [Full Text] [Related]  

  • 17. Cadralazine, a new vasodilator, in addition to a beta-blocker for long-term treatment of hypertension.
    Salvadeo A; Villa G; Segagni S; Piazza V; Picardi L; Romano M; Parini J
    Arzneimittelforschung; 1985; 35(3):623-5. PubMed ID: 2859865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anti-hypertensive therapy in geriatrics].
    Mangano D
    Minerva Med; 1970 Apr; 61(29):1426-8. PubMed ID: 5446158
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical trial of hydrazine sulfate in solid tumors.
    Lerner HJ; Regelson W
    Cancer Treat Rep; 1976 Jul; 60(7):959-60. PubMed ID: 1009529
    [No Abstract]   [Full Text] [Related]  

  • 20. [The results of a clinical study of the preparation hydrazine sulfate].
    Filov VA; Danova LA; Gershanovich ML; Ivin BA; Dement'eva NP; Breĭvis PV; Ragaĭshene VP; Kas'ianenko IV; Lisitsa AM; Mindlin SS
    Vopr Onkol; 1990; 36(6):721-6. PubMed ID: 2198698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.